Automated Blood Sampling in a Canine Telemetry Cardiovascular Model

Area of Science:

• Cardiovascular research
• Pharmacokinetics
• Drug development

Background:

• Cardiovascular assessment and drug analysis are crucial in early drug development.
• Existing models often require separate studies, increasing timelines and animal usage.
• Canine telemetry models offer valuable cardiovascular insights but integrating blood sampling has been challenging.

Purpose of the Study:

• To implement automated blood sampling (ABS) in a canine cardiovascular telemetry model.
• To enable simultaneous cardiovascular assessment and serial blood collection for drug and biomarker analysis.
• To enhance the efficiency, reproducibility, and ethical considerations (3Rs) of preclinical cardiovascular studies.

Main Methods:

• Instrumentation of purpose-bred male Beagle dogs (n=36) with dual-pressure telemetry transmitters and vascular access ports.
• Modifications to acclimation, surgical procedures, and housing for ABS integration.
• Validation of the combined telemetry-ABS system for simultaneous data collection.

Main Results:

• Successful implementation of ABS in the canine telemetry model.
• Demonstrated ability to collect multiple blood samples for drug levels, cytokines, and biomarkers.
• Combined pharmacokinetic and cardiovascular data acquisition achieved.

Conclusions:

• The telemetry-ABS model provides an efficient method for early cardiovascular safety and pharmacokinetic profiling.
• This integrated approach supports refinement and reduction principles in preclinical research.
• The model accelerates drug development timelines and reduces compound requirements.